Bradley T. King

Array ( [id] => 9020507 [patent_doc_number] => 08530493 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'Indolopyridines as Eg5 kinesin modulators' [patent_app_type] => utility [patent_app_number] => 12/280424 [patent_app_country] => US [patent_app_date] => 2007-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 89735 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12280424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8352069 [patent_doc_number] => 08247398 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Zinc complexes of natural amino acids for treating elevated copper caused toxicities' [patent_app_type] => utility [patent_app_number] => 11/707329 [patent_app_country] => US [patent_app_date] => 2007-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3524 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11707329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5126449 [patent_doc_number] => 20070238720 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-10-11 [patent_title] => 'Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures' [patent_app_type] => utility [patent_app_number] => 11/706932 [patent_app_country] => US [patent_app_date] => 2007-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 25582 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0238/20070238720.pdf [firstpage_image] =>[orig_patent_app_number] => 11706932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5070358 [patent_doc_number] => 20070191460 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-16 [patent_title] => 'Use of Benzo-Heteroaryl Sulfamide Derivatives for the Treatment of Disease Modification / Epileptogenesis' [patent_app_type] => utility [patent_app_number] => 11/673713 [patent_app_country] => US [patent_app_date] => 2007-02-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 20060 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0191/20070191460.pdf [firstpage_image] =>[orig_patent_app_number] => 11673713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259676 [patent_doc_number] => 20070213308 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Methods, compositions, and kits for the treatment of musculoskeletal disorders and symptoms associated therewith' [patent_app_type] => utility [patent_app_number] => 11/698240 [patent_app_country] => US [patent_app_date] => 2007-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 28038 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213308.pdf [firstpage_image] =>[orig_patent_app_number] => 11698240 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5189124 [patent_doc_number] => 20070167433 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-19 [patent_title] => '3,4,5-Substituted piperidines as therapeutic compounds' [patent_app_type] => utility [patent_app_number] => 11/655108 [patent_app_country] => US [patent_app_date] => 2007-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 59456 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20070167433.pdf [firstpage_image] =>[orig_patent_app_number] => 11655108 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7682179 [patent_doc_number] => 20100022629 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'Dietary Methods and Compositions for Enhancing Metabolism and Reducing Reactive Oxygen Species' [patent_app_type] => utility [patent_app_number] => 12/160888 [patent_app_country] => US [patent_app_date] => 2007-01-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 8893 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022629.pdf [firstpage_image] =>[orig_patent_app_number] => 12160888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4670504 [patent_doc_number] => 20080045564 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-02-21 [patent_title] => 'QUININE PRODUCTS, METHOD OF MANUFACTURE, METHOD OF USE' [patent_app_type] => utility [patent_app_number] => 11/620319 [patent_app_country] => US [patent_app_date] => 2007-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26797 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0045/20080045564.pdf [firstpage_image] =>[orig_patent_app_number] => 11620319 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8352123 [patent_doc_number] => 08247454 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-08-21 [patent_title] => 'Liquid antibacterial compositions incorporating trichlorocarbanilide with reduced water activity' [patent_app_type] => utility [patent_app_number] => 12/096896 [patent_app_country] => US [patent_app_date] => 2006-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2616 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 133 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12096896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9620941 [patent_doc_number] => 08791115 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-07-29 [patent_title] => 'Combination of triazine derivatives and insulin sensitisers' [patent_app_type] => utility [patent_app_number] => 12/160664 [patent_app_country] => US [patent_app_date] => 2006-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6062 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12160664 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8146748 [patent_doc_number] => 08163749 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-04-24 [patent_title] => 'Six-membered heterocycles useful as serine protease inhibitors' [patent_app_type] => utility [patent_app_number] => 12/097080 [patent_app_country] => US [patent_app_date] => 2006-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41215 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/163/08163749.pdf [firstpage_image] =>[orig_patent_app_number] => 12097080 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5063682 [patent_doc_number] => 20070225322 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-27 [patent_title] => 'COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF-THE NIGHT INSOMNIA' [patent_app_type] => utility [patent_app_number] => 11/565486 [patent_app_country] => US [patent_app_date] => 2006-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 25194 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0225/20070225322.pdf [firstpage_image] =>[orig_patent_app_number] => 11565486 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5166153 [patent_doc_number] => 20070287740 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-12-13 [patent_title] => 'Compositions and methods of treating middle-of-the night insomnia' [patent_app_type] => utility [patent_app_number] => 11/606640 [patent_app_country] => US [patent_app_date] => 2006-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 24245 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20070287740.pdf [firstpage_image] =>[orig_patent_app_number] => 11606640 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436273 [patent_doc_number] => 20090170860 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Use of PARP-1 Inhibitors' [patent_app_type] => utility [patent_app_number] => 12/094744 [patent_app_country] => US [patent_app_date] => 2006-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3390 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170860.pdf [firstpage_image] =>[orig_patent_app_number] => 12094744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5079259 [patent_doc_number] => 20070122483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Fluocinolone acetonide drug substance polymorphic interconversion' [patent_app_type] => utility [patent_app_number] => 11/604552 [patent_app_country] => US [patent_app_date] => 2006-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 1124 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20070122483.pdf [firstpage_image] =>[orig_patent_app_number] => 11604552 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5386343 [patent_doc_number] => 20090227588 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-09-10 [patent_title] => 'Substituted pyrazole compounds useful as soluble epoxide hyrolase inhibitors' [patent_app_type] => utility [patent_app_number] => 12/095928 [patent_app_country] => US [patent_app_date] => 2006-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37463 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0227/20090227588.pdf [firstpage_image] =>[orig_patent_app_number] => 12095928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7515437 [patent_doc_number] => 08039509 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-18 [patent_title] => 'Composition comprising (−)-Δ9-trans-tetrahydrocannabinol' [patent_app_type] => utility [patent_app_number] => 11/595682 [patent_app_country] => US [patent_app_date] => 2006-11-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3378 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/039/08039509.pdf [firstpage_image] =>[orig_patent_app_number] => 11595682 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4983415 [patent_doc_number] => 20070087974 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-19 [patent_title] => 'TREATMENT OR PREVENTION OF RESPIRATORY VIRAL INFECTIONS WITH IMMUNOMODULATOR COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 11/558281 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 2410 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20070087974.pdf [firstpage_image] =>[orig_patent_app_number] => 11558281 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5368542 [patent_doc_number] => 20090306101 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-10 [patent_title] => 'COMBINATION TREATMENT OF CANCER COMPRISING EGFR/HER2 INHIBITORS' [patent_app_type] => utility [patent_app_number] => 12/093322 [patent_app_country] => US [patent_app_date] => 2006-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17806 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0306/20090306101.pdf [firstpage_image] =>[orig_patent_app_number] => 12093322 [rel_patent_id] =>[rel_patent_doc_number] =>)